Annual EBITDA:
-$216.24M-$73.03M(-51.00%)Summary
- As of today, KYMR annual EBITDA is -$216.24 million, with the most recent change of -$73.03 million (-51.00%) on December 31, 2024.
- During the last 3 years, KYMR annual EBITDA has fallen by -$118.59 million (-121.45%).
- KYMR annual EBITDA is now -917.77% below its all-time high of -$21.25 million, reached on December 31, 2018.
Performance
KYMR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$86.52M-$4.04M(-4.90%)Summary
- As of today, KYMR quarterly EBITDA is -$86.52 million, with the most recent change of -$4.04 million (-4.90%) on September 30, 2025.
- Over the past year, KYMR quarterly EBITDA has dropped by -$16.39 million (-23.38%).
- KYMR quarterly EBITDA is now -1040.93% below its all-time high of -$7.58 million, reached on September 30, 2020.
Performance
KYMR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$320.15M-$16.39M(-5.40%)Summary
- As of today, KYMR TTM EBITDA is -$320.15 million, with the most recent change of -$16.39 million (-5.40%) on September 30, 2025.
- Over the past year, KYMR TTM EBITDA has dropped by -$131.15 million (-69.39%).
- KYMR TTM EBITDA is now -2645.48% below its all-time high of -$11.66 million, reached on September 30, 2019.
Performance
KYMR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KYMR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -51.0% | -23.4% | -69.4% |
| 3Y3 Years | -121.5% | -96.3% | -108.3% |
| 5Y5 Years | -435.6% | -1040.9% | -633.1% |
KYMR EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -121.5% | at low | -369.0% | at low | -108.3% | at low |
| 5Y | 5-Year | -435.6% | at low | -1040.9% | at low | -633.1% | at low |
| All-Time | All-Time | -917.8% | at low | -1040.9% | at low | -2645.5% | at low |
KYMR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$86.52M(-4.9%) | -$320.15M(-5.4%) |
| Jun 2025 | - | -$82.47M(-13.9%) | -$303.76M(-12.4%) |
| Mar 2025 | - | -$72.38M(+8.1%) | -$270.31M(-8.4%) |
| Dec 2024 | -$216.24M(-51.0%) | -$78.78M(-12.3%) | -$249.34M(-31.9%) |
| Sep 2024 | - | -$70.12M(-43.0%) | -$189.00M(-7.7%) |
| Jun 2024 | - | -$49.02M(+4.6%) | -$175.49M(-3.9%) |
| Mar 2024 | - | -$51.41M(-178.7%) | -$168.94M(-4.3%) |
| Dec 2023 | -$143.20M(+5.6%) | -$18.45M(+67.4%) | -$161.97M(+10.7%) |
| Sep 2023 | - | -$56.61M(-33.3%) | -$181.33M(-7.4%) |
| Jun 2023 | - | -$42.48M(+4.4%) | -$168.80M(-1.4%) |
| Mar 2023 | - | -$44.43M(-17.5%) | -$166.43M(-5.2%) |
| Dec 2022 | -$151.66M | -$37.81M(+14.2%) | -$158.24M(-2.9%) |
| Sep 2022 | - | -$44.08M(-9.9%) | -$153.73M(-11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$40.11M(-10.7%) | -$137.59M(-13.1%) |
| Mar 2022 | - | -$36.23M(-8.8%) | -$121.65M(-24.0%) |
| Dec 2021 | -$97.64M(-123.4%) | -$33.31M(-19.2%) | -$98.11M(-27.3%) |
| Sep 2021 | - | -$27.94M(-15.5%) | -$77.08M(-35.9%) |
| Jun 2021 | - | -$24.18M(-90.6%) | -$56.73M(-22.4%) |
| Mar 2021 | - | -$12.68M(-3.2%) | -$46.35M(-4.1%) |
| Dec 2020 | -$43.72M(-8.3%) | -$12.29M(-62.0%) | -$44.53M(-2.0%) |
| Sep 2020 | - | -$7.58M(+45.1%) | -$43.67M(+8.5%) |
| Jun 2020 | - | -$13.80M(-27.1%) | -$47.75M(-40.7%) |
| Mar 2020 | - | -$10.86M(+4.9%) | -$33.94M(-47.0%) |
| Dec 2019 | -$40.38M(-90.0%) | -$11.42M(+2.0%) | -$23.08M(-98.0%) |
| Sep 2019 | - | -$11.66M | -$11.66M |
| Dec 2018 | -$21.25M | - | - |
FAQ
- What is Kymera Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Kymera Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Kymera Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Kymera Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of KYMR is -$216.24M
What is the all-time high annual EBITDA for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high annual EBITDA is -$21.25M
What is Kymera Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, KYMR annual EBITDA has changed by -$73.03M (-51.00%)
What is Kymera Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of KYMR is -$86.52M
What is the all-time high quarterly EBITDA for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high quarterly EBITDA is -$7.58M
What is Kymera Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, KYMR quarterly EBITDA has changed by -$16.39M (-23.38%)
What is Kymera Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of KYMR is -$320.15M
What is the all-time high TTM EBITDA for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high TTM EBITDA is -$11.66M
What is Kymera Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, KYMR TTM EBITDA has changed by -$131.15M (-69.39%)